{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:12:52Z","timestamp":1783599172639,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.thorsurg.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T19:17:07Z","timestamp":1601579827000},"page":"435-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preoperative Identification of Benefit from Surgery for Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"30","author":[{"given":"Isabelle","family":"Opitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Furrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thorsurg.2020.08.003_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-publhealth-031811-124704","article-title":"The worldwide pandemic of asbestos-related diseases","volume":"34","author":"Stayner","year":"2013","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.thorsurg.2020.08.003_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-10862-4_2","article-title":"Epidemiology of mesothelioma and historical background","volume":"189","author":"Craighead","year":"2011","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S2213-2600(19)30004-9","article-title":"Pleural mesothelioma: tackling a deadly cancer","volume":"7","author":"The Lancet Respiratory","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.003_bib4","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.thorsurg.2020.08.003_bib5","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1111\/crj.12938","article-title":"Current treatments and trials in malignant pleural mesothelioma","volume":"12","author":"Bibby","year":"2018","journal-title":"Clin Respir J"},{"issue":"13","key":"10.1016\/j.thorsurg.2020.08.003_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thx.31.1.15","article-title":"Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients","volume":"31","author":"Butchart","year":"1976","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1183\/09031936.00063109","article-title":"Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma","volume":"35","author":"Scherpereel","year":"2010","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.003_bib9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ejcts.2007.01.061","article-title":"Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results","volume":"31","author":"Edwards","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.003_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thorax.55.9.731","article-title":"Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems","volume":"55","author":"Edwards","year":"2000","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/19338240903390271","article-title":"Prognostic factors for 100 patients with malignant pleural mesothelioma","volume":"65","author":"Gonlugur","year":"2010","journal-title":"Arch Environ Occup Health"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib14","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/carcin\/bgz103","article-title":"Biomarkers for malignant pleural mesothelioma: a meta-analysis","volume":"40","author":"Gillezeau","year":"2019","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","article-title":"Inflammation-based prognostic indices in malignant pleural mesothelioma","volume":"7","author":"Pinato","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/SLA.0b013e3182602af4","article-title":"Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysis","volume":"256","author":"Ghanim","year":"2012","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib17","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/bjc.2013.815","article-title":"Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma","volume":"110","author":"Ghanim","year":"2014","journal-title":"Br J Cancer"},{"issue":"17","key":"10.1016\/j.thorsurg.2020.08.003_bib18","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2007.09.003","volume":"50","author":"Fleisher","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","article-title":"Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement","volume":"196","author":"Culver","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.003_bib20","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population","volume":"5","author":"Flores","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.003_bib21","doi-asserted-by":"crossref","first-page":"e0145039","DOI":"10.1371\/journal.pone.0145039","article-title":"Determinants of survival in malignant pleural mesothelioma: a surveillance, epidemiology, and end results (SEER) study of 14,228 patients","volume":"10","author":"Taioli","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.6004\/jnccn.2012.0006","article-title":"Malignant pleural mesothelioma","volume":"10","author":"Ettinger","year":"2012","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.003_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cllc.2016.03.002","article-title":"Impact of age on long-term outcomes of surgery for malignant pleural mesothelioma","volume":"17","author":"Yang","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.thorsurg.2020.08.003_bib25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.12688\/f1000research.15512.2","article-title":"Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort [version 2; peer review: 2 approved, 1 approved with reservations]","volume":"7","author":"Amin","year":"2018","journal-title":"F1000Res"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","article-title":"Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients","volume":"9","author":"Bovolato","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.003_bib27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/1759-7714.13063","article-title":"Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database","volume":"10","author":"Zhuo","year":"2019","journal-title":"Thorac Cancer"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.athoracsur.2014.04.040","article-title":"Women with malignant pleural mesothelioma have a threefold better survival rate than men","volume":"98","author":"Taioli","year":"2014","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.003_bib29","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/bjc.2014.478","article-title":"Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales","volume":"111","author":"Linton","year":"2014","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib30","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-08-4523","article-title":"Estrogen receptor-beta affects the prognosis of human malignant mesothelioma","volume":"69","author":"Pinton","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/carcin\/bgz004","article-title":"Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database","volume":"40","author":"Van Gerwen","year":"2019","journal-title":"Carcinogenesis"},{"issue":"28","key":"10.1016\/j.thorsurg.2020.08.003_bib32","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","volume":"23","author":"van Meerbeeck","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/bjc.2014.312","article-title":"Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey","volume":"111","author":"Ceresoli","year":"2014","journal-title":"Br J Cancer"},{"issue":"34","key":"10.1016\/j.thorsurg.2020.08.003_bib34","doi-asserted-by":"crossref","first-page":"57460","DOI":"10.18632\/oncotarget.15404","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib35","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib36","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1038\/s41598-020-62813-2","article-title":"Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibition","volume":"10","author":"Ghanim","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21037\/tlcr.2017.05.06","article-title":"Diagnostic and prognostic biomarkers for malignant mesothelioma: an update","volume":"6","author":"Chen","year":"2017","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/atm.2017.06.60","article-title":"Diagnosis and prognosis\u2014review of biomarkers for mesothelioma","volume":"5","author":"Sun","year":"2017","journal-title":"Ann Transl Med"},{"issue":"31","key":"10.1016\/j.thorsurg.2020.08.003_bib39","doi-asserted-by":"crossref","first-page":"50417","DOI":"10.18632\/oncotarget.10413","article-title":"HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.thorsurg.2020.08.003_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2407-13-205","article-title":"Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma","volume":"13","author":"Tabata","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lungcan.2015.07.014","article-title":"Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma","volume":"90","author":"Yamagishi","year":"2015","journal-title":"Lung Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.thorsurg.2020.08.003_bib42","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","article-title":"British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma","volume":"73","author":"Woolhouse","year":"2018","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/RCT.0000000000000174","article-title":"Use of computed tomography and positron emission tomography\/computed tomography for staging of local extent in patients with malignant pleural mesothelioma","volume":"39","author":"Frauenfelder","year":"2015","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.thorsurg.2020.08.003_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lungcan.2016.01.017","article-title":"Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET\/CT in local thoracic staging of malignant pleural mesothelioma","volume":"94","author":"Martini","year":"2016","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/rg.241035058","article-title":"Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET","volume":"24","author":"Wang","year":"2004","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.003_bib46","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0003-4975(99)01038-3","article-title":"Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically","volume":"68","author":"Rusch","year":"1999","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1183\/09031936.00146110","article-title":"Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?","volume":"38","author":"Frauenfelder","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.thorsurg.2020.08.003_bib48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lungcan.2016.09.003","article-title":"Imaging in pleural mesothelioma: A review of the 13th international conference of the international mesothelioma interest group","volume":"101","author":"Armato","year":"2016","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.003_bib49","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-010-1107-z","article-title":"Volume-based parameter of 18)F-FDG PET\/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications","volume":"17","author":"Lee","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.003_bib50","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jtho.2016.09.124","article-title":"The IASLC Mesothelioma Staging Project: proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Mesothelioma","volume":"11","author":"Rusch","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.003_bib51","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jtho.2016.08.147","article-title":"The IASLC mesothelioma staging project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma","volume":"11","author":"Nowak","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","article-title":"Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients","volume":"117","author":"Sugarbaker","year":"1999","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.003_bib53","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1200\/JCO.1993.11.6.1172","article-title":"Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma","volume":"11","author":"Sugarbaker","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.thorsurg.2020.08.003_bib54","first-page":"C23","article-title":"[Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma]","volume":"13","author":"Scherpereel","year":"2010","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.003_bib55","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.jtho.2016.09.121","article-title":"The IASLC mesothelioma staging project: proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma","volume":"11","author":"Rice","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib56","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.cllc.2020.01.002","article-title":"Impact of detecting occult pathologic nodal disease during resection for malignant pleural mesothelioma","volume":"21","author":"Verma","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.003_bib57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.crad.2019.12.001","article-title":"The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines","volume":"75","author":"Sinha","year":"2020","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-5002(03)00292-7","article-title":"Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma","volume":"43","author":"van Klaveren","year":"2004","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Byrne","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.003_bib60","first-page":"127","article-title":"Clinical staging of malignant pleural mesothelioma: current perspectives","volume":"8","author":"Bonomi","year":"2017","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.thorsurg.2020.08.003_bib61","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1118\/1.1688211","article-title":"Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques","volume":"31","author":"Armato","year":"2004","journal-title":"Med Phys"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib62","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JOP.17.00012","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline summary","volume":"14","author":"Kindler","year":"2018","journal-title":"J\u00a0Oncol Pract"},{"issue":"18","key":"10.1016\/j.thorsurg.2020.08.003_bib63","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","article-title":"Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma","volume":"27","author":"Krug","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib64","first-page":"034503","article-title":"Deep convolutional neural networks for the automated segmentation of malignant pleural mesothelioma on computed tomography scans","volume":"5","author":"Gudmundsson","year":"2018","journal-title":"J\u00a0Med Imaging (Bellingham)"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib65","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.athoracsur.2016.06.069","article-title":"A\u00a0multicenter study of volumetric computed tomography for staging malignant pleural mesothelioma","volume":"102","author":"Rusch","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.003_bib66","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/JTO.0b013e3181dd0ef1","article-title":"Assessment of therapy responses and prediction of survival in malignant pleural mesothelioma through computer-aided volumetric measurement on computed tomography scans","volume":"5","author":"Liu","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.003_bib67","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00330-008-0918-9","article-title":"Therapy response in malignant pleural mesothelioma-role of MRI using RECIST, modified RECIST and volumetric approaches in comparison with CT","volume":"18","author":"Plathow","year":"2008","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib68","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/annonc\/mds535","article-title":"Disease volumes as a marker for patient response in malignant pleural mesothelioma","volume":"24","author":"Labby","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2020.08.003_bib69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lungcan.2018.11.033","article-title":"Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group","volume":"130","author":"Armato","year":"2019","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib70","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/JTO.0b013e31828354c8","article-title":"Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma","volume":"8","author":"Labby","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0022-5223(98)70274-0","article-title":"Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma","volume":"115","author":"Pass","year":"1998","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1118\/1.3525836","article-title":"Computerized segmentation and measurement of malignant pleural mesothelioma","volume":"38","author":"Sensakovic","year":"2011","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.003_bib74","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/0284186X.2018.1445283","article-title":"Influence of inter-observer delineation variability on radiomics stability in different tumor sites","volume":"57","author":"Pavic","year":"2018","journal-title":"Acta Oncol"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.003_bib75","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/01.rli.0000131888.39636.c5","article-title":"Asbestos-related pleural disease: value of dedicated magnetic resonance imaging techniques","volume":"39","author":"Weber","year":"2004","journal-title":"Invest Radiol"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.003_bib76","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.jtcvs.2019.11.035","article-title":"Preoperative prediction of unresectability in malignant pleural mesothelioma","volume":"159","author":"Burt","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib77","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.lungcan.2013.08.005","article-title":"Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group","volume":"82","author":"Armato","year":"2013","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib78","doi-asserted-by":"crossref","first-page":"e0229299","DOI":"10.1371\/journal.pone.0229299","article-title":"Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET\/CT scan in patients with malignant pleural mesothelioma","volume":"15","author":"Lim","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib79","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1186\/s12885-018-5064-4","article-title":"Systematic review of quality of life following pleurectomy decortication and extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"18","author":"Schwartz","year":"2018","journal-title":"BMC cancer"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.lungcan.2011.12.009","article-title":"Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure","volume":"77","author":"Rena","year":"2012","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib81","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0218492312454017","article-title":"Changes in lung function after surgery for mesothelioma","volume":"21","author":"Ploenes","year":"2013","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib82","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ejcts\/ezt664","article-title":"Predictors of long-term survival following radical surgery for malignant pleural mesothelioma","volume":"46","author":"Nakas","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.thorsurg.2020.08.003_bib84","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.21037\/tlcr.2020.01.08","article-title":"Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma","volume":"9","author":"Woodard","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.003_bib85","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to The 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/his.14105","article-title":"Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma","volume":"77","author":"Bilecz","year":"2020","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.003_bib87","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/09031936.00000811","article-title":"Predicting survival in malignant mesothelioma","volume":"38","author":"Musk","year":"2011","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib88","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.athoracsur.2017.09.036","article-title":"National trends in the epidemiology of malignant pleural mesothelioma: a national cancer data base study","volume":"105","author":"Saddoughi","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib89","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ejcts.2008.06.010","article-title":"Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy","volume":"34","author":"Nakas","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib90","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijsu.2008.04.004","article-title":"Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma","volume":"6","author":"Neragi-Miandoab","year":"2008","journal-title":"Int J Surg"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib91","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular changes in mesothelioma with an impact on prognosis and treatment","volume":"136","author":"Jean","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib92","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib93","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"7006","key":"10.1016\/j.thorsurg.2020.08.003_bib95","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib96","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Kirschner","year":"2015","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib97","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejcts.2007.09.045","article-title":"PTEN expression is a strong predictor of survival in mesothelioma patients","volume":"33","author":"Opitz","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.thorsurg.2020.08.003_bib98","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/JTO.0000000000000055","article-title":"PI3K\/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy","volume":"9","author":"Bitanihirwe","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib99","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ejcts.2009.08.027","article-title":"Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma","volume":"37","author":"Schramm","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib100","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.21873\/anticanres.13833","article-title":"The mTOR signaling pathway is associated with the prognosis of malignant pleural mesothelioma after multimodality therapy","volume":"39","author":"Kuroda","year":"2019","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.003_bib101","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/bjc.2014.117","article-title":"CD74: a new prognostic factor for patients with malignant pleural mesothelioma","volume":"110","author":"Otterstrom","year":"2014","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.thorsurg.2020.08.003_bib102","doi-asserted-by":"crossref","first-page":"e0139312","DOI":"10.1371\/journal.pone.0139312","article-title":"Expression of the stem cell factor nestin in malignant pleural mesothelioma is associated with poor prognosis","volume":"10","author":"Thies","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.003_bib103","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.molonc.2016.06.005","article-title":"Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma","volume":"10","author":"Meerang","year":"2016","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib104","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajco.12788","article-title":"PD-L1 expression associated with worse survival outcome in malignant pleural mesothelioma","volume":"14","author":"Nguyen","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.003_bib105","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.21037\/jtd.2016.07.55","article-title":"Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma","volume":"8","author":"Sandri","year":"2016","journal-title":"J\u00a0Thorac Dis"},{"issue":"3","key":"10.1016\/j.thorsurg.2020.08.003_bib106","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.athoracsur.2015.04.087","article-title":"Prognostic score of long-term survival after surgery for malignant pleural mesothelioma: a multicenter analysis","volume":"100","author":"Leuzzi","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib107","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2020.08.003_bib108","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/JTO.0000000000000181","article-title":"Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee","volume":"9","author":"Pass","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"12","key":"10.1016\/j.thorsurg.2020.08.003_bib109","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.thorsurg.2020.08.003_bib110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A\u00a0novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis","volume":"11","author":"Brims","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2020.08.003_bib111","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cllc.2019.08.003","article-title":"Development of a novel prognostic risk classification system for malignant pleural mesothelioma","volume":"21","author":"Doi","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"8","key":"10.1016\/j.thorsurg.2020.08.003_bib112","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/annonc\/mdy195","article-title":"Pleural mesothelioma: is the surgeon still there?","volume":"29","author":"Opitz","year":"2018","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.thorsurg.2020.08.003_bib113","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/JTO.0000000000000661","article-title":"A\u00a0new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma: a review of 12 years' experience","volume":"10","author":"Opitz","year":"2015","journal-title":"J\u00a0Thorac Oncol"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412720300657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:34:29Z","timestamp":1761546869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412720300657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":113,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1547412720300657"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.003","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Identification of Benefit from Surgery for Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}